Neoadjuvant anti-OX40 (MEDI6469) therapy in patients with head and neck squamous cell carcinoma activates and expands antigen-specific tumor-infiltrating T cells
Rebekka Duhen(Oregon Health & Science University), Andrew D. Weinberg(Providence Portland Medical Center)
Cited by 154
Related Papers
Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors
|Nature Communications|2018|927
HIV-1 Nef Assembles a Src Family Kinase-ZAP-70/Syk-PI3K Cascade to Downregulate Cell-Surface MHC-I
|Cell Host & Microbe|2007|105
PD-1 and ICOS coexpression identifies tumor-reactive CD4+ T cells in human solid tumors
|Journal of Clinical Investigation|2022|70